Bilateral optic neuritis and myocarditis after the first dose of COVID-19 vaccine
Neuroimmunology Reports
; 2 (no pagination), 2022.
Article
in English
| EMBASE | ID: covidwho-2290562
ABSTRACT
Since the introduction of COVID-19 vaccine, various adverse events have been reported including injection site pain, fatigue, headaches, and myocarditis. Cranial neuropathies and optic neuritis, have been also rarely reported, however, the significance of these autoimmune manifestations after the administration of COVID-19 vaccine remain controversial. In this report we present a case of myocarditis and bilateral optic neuritis that occurred in a young healthy male patient after the administration of first dose of mRNA-1273 vaccine (Moderna).Copyright © 2022 The Author(s)
adult; article; atrophy; case report; cerebrospinal fluid analysis; chest tightness; clinical article; contrast sensitivity; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/pc [Prevention]; drug dose reduction; dyspnea; eye examination; fluoroscopy; heart palpitation; human; intraocular hemorrhage; lumbar puncture; male; myocarditis/si [Side Effect]; night sweat; optic neuritis/dt [Drug Therapy]; optic neuritis/si [Side Effect]; pallor; papilledema; papillitis; perimetry; priority journal; pupil disease; thorax pain; vaccination; visual impairment; elasomeran/ae [Adverse Drug Reaction]; elasomeran/dt [Drug Therapy]; methylprednisolone/dt [Drug Therapy]; methylprednisolone/iv [Intravenous Drug Administration]; prednisone/dt [Drug Therapy]; prednisone/po [Oral Drug Administration]; troponin/ec [Endogenous Compound]; color vision tester; relative afferent pupillary deficit; mRNA 1273; Ishihara plate
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
English
Journal:
Neuroimmunology Reports
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS